Correlation Between Novartis and Redhill Biopharma
Can any of the company-specific risk be diversified away by investing in both Novartis and Redhill Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Redhill Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Redhill Biopharma, you can compare the effects of market volatilities on Novartis and Redhill Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Redhill Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Redhill Biopharma.
Diversification Opportunities for Novartis and Redhill Biopharma
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novartis and Redhill is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Redhill Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Redhill Biopharma and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Redhill Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Redhill Biopharma has no effect on the direction of Novartis i.e., Novartis and Redhill Biopharma go up and down completely randomly.
Pair Corralation between Novartis and Redhill Biopharma
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.33 times more return on investment than Redhill Biopharma. However, Novartis AG ADR is 2.99 times less risky than Redhill Biopharma. It trades about 0.28 of its potential returns per unit of risk. Redhill Biopharma is currently generating about -0.08 per unit of risk. If you would invest 9,714 in Novartis AG ADR on November 3, 2024 and sell it today you would earn a total of 758.00 from holding Novartis AG ADR or generate 7.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novartis AG ADR vs. Redhill Biopharma
Performance |
| Timeline |
| Novartis AG ADR |
| Redhill Biopharma |
Novartis and Redhill Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and Redhill Biopharma
The main advantage of trading using opposite Novartis and Redhill Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Redhill Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Redhill Biopharma will offset losses from the drop in Redhill Biopharma's long position.| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
| Redhill Biopharma vs. Organogenesis Holdings | Redhill Biopharma vs. Lifecore Biomedical | Redhill Biopharma vs. Collegium Pharmaceutical | Redhill Biopharma vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |